Objective: Postoperative respiratory adverse events (RAEs) are associated with high rates of morbidity and mortality in general surgery, however, little is known about these complications in the vascular surgery population, a frail subset with multiple comorbidities. The objective of this study was to describe the contemporary incidence of RAEs in vascular surgery patients, the risk factors for this complication, and the overall impact of RAEs on patient outcomes.
Vascular surgery patients have multiple baseline comorbidities, including coronary artery disease (CAD), congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), and tobacco use, placing them at a high risk for postoperative complications. [1] [2] [3] The incidence of adverse events depends on patient characteristics and the surgical procedure, and it is well documented that major postoperative complications confer both short-and long-term influences on patient outcomes and mortality. [4] [5] [6] [7] [8] [9] In the general surgery literature, major respiratory adverse events (RAEs) are associated with some of the highest rates of mortality, specifically a 3-to 18-fold increased risk of in-hospital death. [10] [11] [12] [13] [14] Moreover, postoperative respiratory complications are reported to be the most expensive adverse event, far exceeding the costs of other major complications, such as cardiovascular and infectious events.
Although some studies have reported the incidence of respiratory complications in vascular surgery patients, this adverse event has generally been underappreciated in our surgical population as investigations have been limited to major thoracic and abdominal procedures. 4, [16] [17] [18] [19] [20] Previously published general surgery literature suggests that patients undergoing vascular procedures are at a particularly elevated risk of respiratory complcations. 8, 9, 11, 21, 22 However, there is a paucity of research into the risk factors for developing these clinically significant adverse event in the subset of vascular surgery patients, which can be a particularly frail group requiring complex surgical procedures. Therefore, our objective was to investigate the contemporary incidence of postoperative RAEs in patients undergoing vascular surgery using a multicentered, national database. In addition, we sought to delineate the risk factors for developing respiratory complications and their impact on patient outcomes. The main outcome of interest was postoperative RAEs, which was consistently defined and captured across all of the above procedure types in VQI as pneumonia (lobar infiltrate on chest X ray and pure growth of recognized pathogen or 4þ growth of recognized pathogen in presence of mixed growth) or reintubation after initial extubation. Data were obtained on patient demographics (sex, race, body mass index [ , new cardiac dysrhythmia, CHF exacerbation, cerebrovascular events, acute renal failure, wound infection, distal embolization to the lower extremity, and return to the operating room), and patient outcomes (hospital length of stay, in-hospital mortality, and discharge to a rehabilitation or nursing facility). Variables were used in the analyses if there was less than 20% missing data for the variable and if each category within a given variable had an incidence of at least 1% (>525 patients).
METHODS
Determining risk factors for RAEs. Univariable analysis was performed to determine the association of demographics, comorbidities, and operative variables with postoperative RAEs. Categorical variables were assessed using Pearson c 2 analysis, continuous variables that were normally distributed (preoperative hemoglobin) were assessed with t-test, and continuous variables without a normal distribution (age, estimated blood loss) were assessed using a nonparametric analysis, the MannWhitney U-test, and subsequently converted into groups and analyzed as categorical variables. A mixed-effects logistic regression model was created to determine the adjusted odds ratios (ORs) of risk factors for developing RAEs (demographics, comorbidities, and operative variables) while also controlling for potential clustering of events at each hospital center as the random effect. Variables were entered into the model if on univariable analysis the P value was < .2 and were not significantly correlated (Pearson correlation < .5; P < .05). All model variables were checked for significant interactions using a likelihood ratio test.
Development of the preoperative risk prediction score for RAEs. A random 85% sample of the cohort was used to develop a preoperative risk prediction score for the development of postoperative RAEs. A mixed-effects logistic regression model predicting RAEs was created using only demographics (age, BMI, smoking status, ambulatory status), comorbidities (CHF, COPD, renal insufficiency), transfer status, urgency of the procedure, and operative type. Each variable coefficient was averaged over 10 bootstrapping replications of the model. The averaged coefficient was then adjusted by a scaling factor of 0.2 and rounded to the nearest whole number to obtain a point value for each variable. 23 The predicted probability of a respiratory event was calculated for each point total, 23 and then point totals were clustered into four major risk groups: low risk (<5.0%), intermediate-low risk (5%-10%), intermediate-high risk (10%-20%), and high risk (>20%). The prediction score was validated using the remaining 15% of the cohort. A point total was assigned to each patient based on his or her preoperative risk factors. The area under the receiver operator characteristic curve was calculated after the model was applied to this cohort. For each point total, the predicted incidence of RAEs and the actual incidence of RAEs in the 15% cohort were compared using Pearson correlation, excluding the most extreme 0.5% of patients in which there were less than 10 patients in each point total. In addition, the incidence of RAEs for each risk group was calculated to determine if the actual incidence fell within the predicted risk range.
In conjunction with the VQI and the online and mobile device application Calculate by QxMD (Vancouver, Canada), this risk prediction tool was made available for iOS, Android, and Windows 10 at http://qx.md/ calculate or on the web at http://qxmd.com/resp-vqi, listed under "VQI: Respiratory Adverse Event Risk Post Vascular Surgery."
Impact of RAEs on patient outcomes. The difference in the length of stay for those patients with and without a RAE was compared using a nonparametric MannWhitney U-test. The incidence of in-hospital mortality was calculated for those with and without a RAE and compared using c 2 analysis. An adjusted OR of inhospital death associated with postoperative RAEs was determined by creating a mixed-effects logistic model (random effect ¼ hospital center), controlling for demographics, baseline comorbidities, operative variables, and other postoperative adverse events. Excluding patients with in-hospital mortality, the incidence of discharge to a facility (nursing or rehabilitation center) was calculated for patients with and without a RAE and compared using a c 2 analysis. Again, excluding those with in-hospital mortality, an adjusted OR of discharge to a facility associated with postoperative RAEs was determined by creating a mixed-effects logistic model controlling for demographics, baseline comorbidities, operative variables, and other postoperative adverse events.
RESULTS
The study included 52,562 patients who underwent a major vascular surgery procedure from April 2003 through September 2014. Table I describes the baseline demographics, comorbidities, and operative information of the cohort. The mean patient age was 69.9 6 11.0 (18-89) years with a median age of 70 years. The majority of patients were male, Caucasian, and had hypertension. Baseline cardiac and pulmonary diseases were common; nearly one-third of patients had CAD or COPD, and 86% of patients were active or past smokers. The majority of patients underwent elective procedures, and the most common procedure performed was an infrainguinal bypass (38.7%), followed by EVAR (32.7%), open AAA repair (11.3%), extra-anatomic bypass (6.3%), in situ suprainguinal bypass (6.2%), and TEVAR (4.8%).
The overall incidence of postoperative RAEs was 5.4% (n ¼ 2831); 773 patients had pneumonia (1.5%) and 2058 patients required reintubatation (3.9%). As shown in Table II , RAEs were the third most common postoperative adverse event, following a major transfusion ($3units of packed red blood cell) (12.5% incidence) and any type of cardiac event (8.9% overall incidence, with 5.6% of patients developing a new dysrhythmia, 3.1% suffering an AMI, and 2.5% with a CHF exacerbation). Adverse events less frequent than RAEs were wound complications or infection, acute renal failure, and cerebrovascular events.
Risk factors for the development of RAEs. Table III details the incidence of RAEs for each preoperative and operative variable. Of note, RAEs occurred more frequently in females, underweight, older, and nonambulatory patients. Compared with former or never smokers, current smokers had the highest incidence of RAEs at a rate of 6.1% (P < .0001); there was no significant difference between the rates of RAEs for never smokers and former smokers (cessation for $1 year) (5.2% and 4.8%, respectively; P ¼ .192). Patients with the highest rates of RAEs were those with a recent AMI (within 6 months) or unstable angina (10.1%), symptomatic CHF (9.9%), COPD (7.8%), and COPD requiring oxygen therapy (11.0%). In addition, patients with ASA classifications IV and V had significantly higher rates of RAEs (9.4% and 36.6%, respectively). Operative variables highly associated with postoperative RAEs were urgent and emergent procedures (6.4% and 25.9%, respectively), open AAA repairs (17.6%), in situ suprainguinal bypass (9.68%), and TEVARs (9.6%). Patients with RAEs had significantly longer operative lengths (median, 3.77 hours vs 3.0 hours; P < .0001) and lower hemoglobin at presentation (mean 12.0 6 2.48 g/dL vs 13.0 6 2.16 g/dL; P < .0001). A mixed-effects, logistic regression model was performed to identify risk factors for developing postoperative RAEs while controlling for the effect of event clustering at each hospital center (Table IV) . Underweight and morbidly obese patients, compared with normal weight patients, had a significantly increased risk of developing RAEs with an OR of 1.51 (P < .0001) and 1.35 (P ¼ .039), respectively. Conversely, obese patients had a decreased risk, with an OR of 0.84 (P ¼ .022). The risk of RAEs increased with older age, with those >80 years of age conferring the highest risk (OR, 2.09 compared with <50 years of age; P < .0001). Current smokers had an OR of 1.26 compared with nonsmokers (P ¼ .011), while former smokers were not at a significantly higher risk. Increasing severity in COPD carried an increasing risk of RAEs, with those on medications alone having an OR of 1.74 (P < .0001) and those with an oxygen requirement having an OR of 2.33 (P < .0001), compared with patients without COPD. Symptomatic cardiac disease conferred an elevated risk of RAEs (recent AMI or unstable angina OR, 1.50; P ¼ .007 and symptomatic CHF OR, 1.42; P ¼ .001, compared with patients without cardiac disease). Clinical indicators of poorly optimized volume status, such as advanced renal insufficiency (stage 4, OR, 1.96; P < .0001 and stage 5/dialysis, OR, 1.70; P < .0001) and patients with high intraoperative blood loss ($2000 mL, OR, 2.31; P < .0001) had an independent increased risk of RAEs.
Bedbound or wheelchair confined patients were at an increased risk of respiratory events, likely as a marker of Preoperative risk prediction score for RAEs. The preoperative risk prediction score was created using key demographics, comorbidities, level of acuity, and operative type, informed by the above multivariable model (Table V) . The point values for each variable were derived from a random 85% sample of the cohort (n ¼ 44,678). The predictor variables included age, BMI, smoking status, CHF severity, COPD severity, degree of renal insufficiency, ambulatory status, transfer status, urgency, and operative type, with a theoretical total point range of 0-41. Each point total had a calculated, estimated risk of developing a RAE. These point totals were then stratified into four groups based on their associated predicted risk rates. The low-risk group (0-11 points) has a predicted risk of RAE <5%, the intermediate-low risk group (12-15 points) has a predicted risk of RAE between 5% and 10%, the intermediate-high risk group (16) (17) (18) (19) points) has a predicted risk between 10% and 20%, and the high-risk group (20-41 points) has a predicted risk of RAEs >20%. The risk prediction score was then validated on the remaining 15% of the cohort (n ¼ 7884). Each patient was assigned a point total based on the prediction score and an associated predicted risk of developing a RAE. For each point total, we compared the actual incidence of RAEs to the predicted risk of RAE; when plotted on a graph (Fig 1) , the predicted risk and actual incidence of RAEs were highly correlated, with a Pearson correlation coefficient of 0.943 (P < .0001). As seen in Table VI, the actual RAE incidence for each major risk group falls within the predicted risk range for each major risk group. Fig 2 depicts the receiver operator characteristic curve, with the area under the curve of 0.8177, demonstrating the excellent discrimination of the risk prediction model.
Impact of RAEs on patient outcomes.
The mean length of hospital stay for the entire cohort was 7.37 6 16.35 days (median 4 days). Those with RAEs had a significantly longer length of stay of 14 days compared with 4 days for those without a respiratory complication (median; P < .0001). For the entire cohort, the in-hospital mortality rate was 2.8% (n ¼ 1494). The rate of inhospital mortality was only 1.2% (n ¼ 608) for those without a RAE and 25.4% (n ¼ 718) for those with a RAE (P < .0001; 9.4% for those with pneumonia and 31.4% for those with requiring reintubation). If a patient survived to discharge (n ¼ 40,334), 20.6% (n ¼ 10,505) of the entire cohort was discharged to a nursing or rehabilitation facility. Only 19% of patients who did not have a respiratory complication were discharged to a facility, whereas 57.8% (n ¼ 1219) of patients with RAEs were discharged to a facility (P < .0001; Fig 3) . A mixed-effects, logistic regression model was created to determine the independent impact of RAEs on mortality while controlling for baseline patient characteristics (age, sex, BMI, smoking, diabetes, CAD, CHF, COPD, renal insufficiency, stress test, transfer status, preoperative medications, ASA class, urgency, hemoglobin), operative type (procedure, anesthesia, perioperative antibiotics, blood loss, procedure time), other adverse events (transfusion of more than three units of packed red blood cells, any cardiac event, renal failure, wound or graft complication, return to the operating room), the interaction between cardiac and RAEs, and the random effect of clustering at hospital centers. In this model, respiratory complications were associated with an OR of 5.85 (95% confidence interval, 4.61-7.43; P < .0001), which was the highest ORs for any complication and the second highest in the model, behind an ASA class V (compared with class I and II; OR, 6.50; P < .0001). Excluding patients who did not survive to discharge, a similar multivariable model was created to determine association of discharge to a nursing facility; RAEs were associated with an OR of 3.14 (95% confidence interval, 2.72-3.64; P < .0001) of being discharged to a facility.
DISCUSSION
Postoperative respiratory complications are associated with some of the highest rates of morbidity and mortality, with a significant impact on patient quality of life and healthcare costs given the prolonged hospitalization and nursing facility care requirements. 4, 8, 9, 14, 15, 24 The vast majority of the literature examines the incidence and impact of postoperative RAEs in the general surgery patient population, with only a small portion of vascular surgery patients represented in these studied cohorts. 4, 8 Even though these studies are useful in identifying generalized risk factors for RAEs, vascular surgery patients are a unique group with multiple comorbidities, advanced age, high acuity, and complexity of procedures compared with the general surgery population.
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Although few studies have focused on postoperative complications in vascular surgery patients specifically, these have been limited to single center studies, Moreover, these studies have only assessed the impact of respiratory failure on outcomes alone without developing a comprehensive risk model for the development of this morbid complication. 5, 19, 21, 25 Although the frequency of postoperative respiratory complications depends on both patient characteristics and type of surgical intervention, they have been traditionally described as relatively uncommon events, occurring in 1.4%-10% of surgical patients. 5, 11, 22, 26 In our contemporary, vascular surgery patient population, the overall incidence of RAEs was 5.4%, which was more frequent than other postoperative complications that are often the focus of preoperative risk stratification and optimization, such as AMI, CHF exacerbations, and infectious or wound complications. This can be explained by a multiple factors, including a more complex patient population, and more robust reporting mechanism that prompts the capturing of complications. In addition to being one of the most prevalent postoperative adverse events, the current study demonstrates that RAEs are one of the strongest predictors of poor patient outcomes. One-quarter of patients with a RAE died during their hospitalization, with a 5.9 adjusted OR of inhospital mortality associated with RAEs. Lengths of hospital stays were almost three times greater with RAEs, and of those patients who survived, over one-half required rehabilitation or nursing care after discharge, all of which contribute to the large cost burden associated with this complication. 4, 15 In situ suprainguinal bypass 9
Open AAA repair 10 AAA, Abdominal aortic aneurysm; BMI, body mass index; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; EVAR, endovascular aortic repair; TEVAR, thoracic endovascular aortic repair.
There were a variety of baseline patient and operative characteristics that were predictive of RAEs. This included advanced age, which is consistent with previous reports showing age as being highly associated with RAEs, particularly in octogenerians. 8, 11, 14, 22 In addition, active smoking was shown in this study, as well as in previous reports, 8, 9, 11, 14, 22 to be associated with postoperative RAEs, whereas patients who had quit smoking for at least 1 year remained at a similar risk as nonsmokers. BMI was used in this study as it was able to identify patients who were underweight, as malnutrition and low BMI are historically associated with postoperative respiratory complications 8, 9, 11, 14, 22 and those with morbid obesity. The association of morbid obesity with respiratory complications has been conflicting in previous studies, but these patients potentially have a decreased inspiratory capacity due to their body habitus and decreased postoperative rehabilitation ability. 9, [27] [28] [29] [30] Interestingly, those who were overweight or obese were not at an increased risk of RAEs, which may be a marker of adequate nutrition and is consistent with previous findings of similar adverse event rates of obese patients compared with normal weight patients. 11, [31] [32] [33] Other predictive comorbidities that were subsequently included in the risk prediction score included COPD, CHF, and progressive renal insufficiency. As previously demonstrated, baseline COPD represents the underlying pulmonary disease contributing to post-operative respiratory complications, 8, 9, 11, 14, 22 however, the present study has further delineated this risk by differentiating between disease severity and showing that the greatest risk in those with advanced disease requiring oxygen Rates of in-hospital mortality and discharge to a nursing or rehabilitation facility for patients without and with a respiratory adverse event (RAE). *Calculated for patients who survived to discharge (N ¼ 40,334).
therapy. In a similar fashion, our study used CHF severity and degree of renal insufficiency to accurately riskstratify patients. These underlying diseases have been shown to increase the risk of pulmonary complications and likely represent baseline deconditioning, patient frailty, and suboptimal volume status. 8, 9, 11, 14, 22 Ambulatory status was found to be a strong predictor of RAEs, as those who are wheelchair or bed bound have a high degree of deconditioning and functional dependence, with the potential for impaired ability to perform adequate postoperative pulmonary rehabilitation. Indicators of disease acuity, transfer status and urgency of the procedure were included in the risk prediction score as these variables have some of the strongest associations with postoperative complications. 9, 11, 14, 22 Patients who require urgent or emergent procedures are unable to undergo preoperative cardiopulmonary optimization and represent some of the most advanced disease states, placing them at the highest risk for both perioperative complications and mortality. Finally, it is well known that the type of surgical procedure confers different levels of postoperative RAE risk. 8, 9, 11, 22 Even within the subset of vascular procedures, thoracic endovascular procedures and open abdominal cases carried the highest rates of respiratory complications. Open abdominal aneurysm repairs had the highest rates of respiratory complications at 18%, while in situ suprainguinal bypass and TEVAR had RAE rates of approximately 10%. These procedures place a direct stress on the pulmonary system and postoperative rehabilitation can be significantly limited by atelectasis, decreased inspiratory capacity and postoperative pain. Moreover, despite the minimally invasive nature of TEVARs, patients presenting with a major thoracic pathology inherently places them at a higher risk of respiratory complications compared with other endovascular procedures, such as EVAR, which is associated with only a 3% risk of RAEs. As a result of our investigation into the major risk factors for the development of respiratory complications in vascular patients, we developed a risk prediction score that uses 10 major preoperative variables including age, BMI, smoking status, CHF severity, COPD severity, degree of renal insufficiency severity, ambulatory status, transfer status, urgency, and operative type. It stratifies patients into four major risk groups of <5%, 5%-10%, 10%-20%, or >20%. This prediction score was validated with a separate VQI cohort not used for the score generation. The correlation between the predicted and the actual incidence of RAEs was .943, with a c-statistic of .8177, demonstrating the prediction score's excellent discrimination and performance.
This risk prediction score was created to risk stratify individual patients undergoing any major vascular procedure, to be used when seeing a patient for an elective procedure in clinic or prior to a more urgent procedure in the hospital. In the preoperative setting, accurate risk stratification can provide evidence-based counseling of patients with regard to their respiratory complication risk and the subsequent risk of in-hospital mortality and overall disposition. Moreover, this would allow surgeons and primary care physicians to optimize patients prior to elective surgeries, in conjunction with other medical subspecialists, such as pulmonologists, intensivists, and cardiologists, with specific attention to volume status optimization and tobacco cessation prior to an elective procedure. Those at high risk can also be considered for preoperative pulmonary rehabilitation, which may improve the overall conditioning of the patient as well as the patient's inspiratory capacity and muscle training to assist in optimizing the postoperative pulmonary status. 8, 34 In the postoperative setting, those predicated to be at high risk could be placed in an aggressive pain control and pulmonary rehabilitation programs by facilitating deep breathing, reduction in atelectasis, and increase inspiratory capacity. 8, 35, 36 Moreover, as increasing emphasis is being placed on quality outcomes, shortening length of stay while minimizing postoperative complications and decreasing readmission, this risk stratification allows single centers or regulatory agencies to set benchmarks for expected rates of this important adverse events.
This study has some limitations that require acknowledgement. All analyses were performed on data that were obtained from a multicentered database that requires voluntary data and event entry from each hospital. The VQI does perform quality diagnostics on reported data, however, inaccurate and missing data are possible. In addition, prediction scores have the potential to overfit for the database used to develop the score. In an effort to demonstrate the validity of this prediction model, we reserved a random 15% sample of the data from the score development to use in the score validation, as opposed to bootstrapping random samples from the original cohort. However, further application of the risk prediction score to external databases and prospective cohorts are still needed to more thoroughly validate the prediction score. Despite the stated limitations, this large dataset and robust prediction models provide us with a solid description of RAEs and their impact on patients undergoing vascular surgery.
CONCLUSIONS
This study, using the VQI's multicentered, national database, provides an in-depth investigation into a clinically significant postoperative event in the contemporary vascular surgery patient population. RAEs are frequent and one of the strongest risk factors for in-hospital mortality and inability to be discharged home. Using over 52,000 patients, a risk prediction score was developed that accurately stratifies patients based on key demographics, comorbidities, presentation, and operative type that can guide patient counseling, preoperative optimization, postoperative management, and to be used as a quality benchmark measure. This prediction tool ("VQI: Respiratory Adverse Event Risk Post Vascular Surgery") can be found online and on the mobile device application Calculate by QxMD at http://qx.md/calculate or on the web at http://qxmd.com/resp-vqi. 
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